Human intestinal mast cells are a potent source of multiple chemokines

Cytokine

Volumn 58, Issue 2, 2012, Pages 178-185

  Feuser, Katrin ^a   Thon, Klaus Peter ^b   Bischoff, Stephan C ^a   Lorentz, Axel ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Chemokines; IgE; IL 4; Mast cells; SCF

Indexed keywords

CCL1 CHEMOKINE; CCL18 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; FC EPSILON RECEPTOR 1; FC RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL STIMULATION; CROSS LINKING; CYTOKINE RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INTESTINAL MAST CELL; MAST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

BASE SEQUENCE; DNA PRIMERS; FLOW CYTOMETRY; HUMANS; INTESTINES; MAST CELLS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84859217123     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.01.001     Document Type: Article

References (39)

1. Bischoff S.C. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 2007, 7:93-104.
2. Kalesnikoff J., Galli S.J. New developments in mast cell biology. Nat Immunol 2008, 9:1215-1223.
3. Kumar V., Sharma A. Mast cells: emerging sentinel innate immune cells with diverse role in immunity. Mol Immunol 2010, 48:14-25.
4. Galli S.J., Tsai M. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur J Immunol 2010, 40:1843-1851.
5. Metcalfe D.D., Peavy R.D., Gilfillan A.M. Mechanisms of mast cell signaling in anaphylaxis. J Allergy Clin Immunol 2009, 124:639-646.
6. Babina M., Guhl S., Stärke A., Kirchhof L., Zuberbier T., Henz B.M. Comparative cytokine profile of human skin mast cells from two compartments - strong resemblance with monocytes at baseline but induction of IL-5 by IL-4 priming. J Leukoc Biol 2004, 75:244-252.
7. Bischoff S.C., Schwengberg S., Raab R., Manns M.P. Functional properties of human intestinal mast cells cultured in a new culture system: enhancement of IgE receptor-dependent mediator release and response to stem cell factor. J Immunol 1997, 159:5560-5567.
8. Bischoff S.C., Sellge G., Lorentz A., Sebald W., Raab R., Manns M.P. IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci U S A 1999, 96:8080-8085.
9. Lorentz A., Schwengberg S., Sellge G., Manns M.P., Bischoff S.C. Human intestinal mast cells are capable of producing different cytokine profiles: role of IgE receptor cross-linking and IL-4. J Immunol 2000, 164:43-48.
10. Hu Z.Q., Zhao W.H., Shimamura T. Regulation of mast cell development by inflammatory factors. Curr Med Chem 2007, 14:3044-3050.
11. Rivera J., Gilfillan A.M. Molecular regulation of mast cell activation. J Allergy Clin Immunol 2006, 117:1214-1225.
12. Gibbs B.F., Wierecky J., Welker P., Henz B.M., Wolff H.H., Grabbe J. Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues. Exp Dermatol 2001, 10:312-320.
13. Feuser K., Feilhauer K., Staib L., Bischoff S.C., Lorentz A. Akt cross-links IL-4 priming, stem cell factor signaling, and IgE-dependent activation in mature human mast cells. Mol Immunol 2011, 48:546-552.
14. Charo I.F., Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006, 354:610-621.
15. Mantovani A., Bonecchi R., Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 2006, 6:907-918.
16. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000, 18:217-242.
17. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.
18. Bacon K., Baggiolini M., Broxmeyer H., Horuk R., Lindley I., Mantovani A., et al. Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res 2002, 22:1067-1068.
19. Yoshie O. Immune chemokines and their receptors: the key elements in the genesis, homeostasis and function of the immune system. Springer Semin Immunopathol 2000, 22:371-391.
20. Sellge G., Bischoff S.C. Isolation, culture, and characterization of intestinal mast cells. Methods Mol Biol 2006, 315:123-138.
21. Lorentz A., Wilke M., Sellge G., Worthmann H., Klempnauer J., Manns M.P., et al. IL-4-induced priming of human intestinal mast cells for enhanced survival and Th2 cytokine generation is reversible and associated with increased activity of ERK1/2 and c-Fos. J Immunol 2005, 174:6751-6756.
22. Galli S.J., Nakae S., Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005, 6:135-142.
23. Lundequist A., Pejler G. Biological implications of preformed mast cell mediators. Cell Mol Life Sci 2011, 68:965-975.
24. Bischoff S.C., Dahinden C.A. c-Kit ligand: a unique potentiator of mediator release by human lung mast cells. J Exp Med 1992, 175:237-244.
25. Hundley T.R., Gilfillan A.M., Tkaczyk C., Andrade M.V., Metcalfe D.D., Beaven M.A. Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 2004, 104:2410-2417.
26. Nakajima T., Inagaki N., Tanaka H., Tanaka A., Yoshikawa M., Tamari M., et al. Marked increase in CC chemokine gene expression in both human and mouse mast cell transcriptomes following Fcepsilon receptor I cross-linking: an interspecies comparison. Blood 2002, 100:3861-3868.
27. Kato A., Chustz R.T., Ogasawara T., Kulka M., Saito H., Schleimer R.P., et al. Dexamethasone and FK506 inhibit expression of distinct subsets of chemokines in human mast cells. J Immunol 2009, 182:7233-7243.
28. Wakahara S., Fujii Y., Nakao T., Tsuritani K., Hara T., Saito H., et al. Gene expression profiles for Fc epsilon RI, cytokines and chemokines upon Fc epsilon RI activation in human cultured mast cells derived from peripheral blood. Cytokine 2001, 16:143-152.
29. Neves B.M., Cruz M.T., Francisco V., Garcia-Rodriguez C., Silvestre R., Cordeiro-da-Silva A., et al. Differential roles of PI3-Kinase, MAPKs and NF-kappaB on the manipulation of dendritic cell T(h)1/T(h)2 cytokine/chemokine polarizing profile. Mol Immunol 2009, 46:2481-2492.
30. Juremalm M., Nilsson G. Chemokine receptor expression by mast cells. Chem Immunol Allergy 2005, 87:130-144.
31. Romagnani P., de P.A., Beltrame C., Annunziato F., Dente V., Maggi E., et al. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol 1999, 155:1195-1204.
32. Bischoff S.C., Sellge G., Schwengberg S., Lorentz A., Manns M.P. Stem cell factor-dependent survival, proliferation and enhanced releasability of purified mature mast cells isolated from human intestinal tissue 2. Int Arch Allergy Immunol 1999, 118:104-107.
33. Brightling C.E., Ammit A.J., Kaur D., Black J.L., Wardlaw A.J., Hughes J.M., et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 2005, 171:1103-1108.
34. Forster R., Davalos-Misslitz A.C., Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008, 8:362-371.
35. Gombert M., Dieu-Nosjean M.C., Winterberg F., Bunemann E., Kubitza R.C., Da C.L., et al. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol 2005, 174:5082-5091.
36. Williams I.R. CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis. Ann N Y Acad Sci 2006, 1072:52-61.
37. Ben-Baruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis 2008, 25:345-356.
38. Ghadjar P., Rubie C., Aebersold D.M., Keilholz U. The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int J Cancer 2009, 125:741-745.
39. Raynaud C.M., Mercier O., Dartevelle P., Commo F., Olaussen K.A., de M.V., et al. Expression of chemokine receptor CCR6 as a molecular determinant of adrenal metastatic relapse in patients with primary lung cancer. Clin Lung Cancer 2010, 11:187-191.